These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 12180431)
1. Pharmaceutical industry sets new guidelines for marketing to physicians. Psychiatr Serv; 2002 Aug; 53(8):1043. PubMed ID: 12180431 [No Abstract] [Full Text] [Related]
2. Direct-to-consumer prescription drug advertising. Terzian TV Am J Law Med; 1999; 25(1):149-67. PubMed ID: 10207573 [No Abstract] [Full Text] [Related]
3. Drug marketing practices criticized. Wagner L Mod Healthc; 1990 Dec; 20(50):12. PubMed ID: 10108088 [No Abstract] [Full Text] [Related]
4. US drug industry's guidelines on advertising too limited, say critics. Burton B BMJ; 2005 Aug; 331(7514):420. PubMed ID: 16110059 [No Abstract] [Full Text] [Related]
5. Voluntary self-regulatory codes: what should we expect? Lexchin J Am J Bioeth; 2003; 3(3):49-50. PubMed ID: 14594491 [No Abstract] [Full Text] [Related]
6. New DTC guidelines please drug companies, anger critics. Med Health; 2005 Aug; 59(27):5-6. PubMed ID: 16111080 [No Abstract] [Full Text] [Related]
7. Pharmaceutical advertising: from prospectus to marketing. Cambronero-Saiz B J Epidemiol Community Health; 2007 Apr; 61(4):366. PubMed ID: 17372300 [No Abstract] [Full Text] [Related]
8. The PMAC code of marketing practices: time for improvement? Pharmaceutical Manufacturers Association of Canada. Desjardins JG CMAJ; 1997 Feb; 156(3):363-4. PubMed ID: 9033417 [TBL] [Abstract][Full Text] [Related]
9. Regulating pharmaceutical advertising: what will work? Shapiro MF CMAJ; 1997 Feb; 156(3):359-61. PubMed ID: 9033416 [TBL] [Abstract][Full Text] [Related]
10. The regulatory morass: physicians' dealings with pharmaceutical manufacturers. Blehart B J Med Pract Manage; 2003; 19(3):164-5. PubMed ID: 14730825 [No Abstract] [Full Text] [Related]
11. Student rally. Med school attendees write ethics code on drug firms. Romano M Mod Healthc; 2002 May; 32(19):24, 26. PubMed ID: 12038157 [No Abstract] [Full Text] [Related]
12. Drug firms back-pedal on direct advertising. Nature; 2005 Aug; 436(7053):910-1. PubMed ID: 16107811 [No Abstract] [Full Text] [Related]
13. Enforcement of codes governing pharmaceutical promotion: what happens when companies breach advertising guidelines? Lexchin J CMAJ; 1997 Feb; 156(3):351-6. PubMed ID: 9033415 [TBL] [Abstract][Full Text] [Related]
14. Marketing pharmaceutical products to physicians. Sales reps influence physicians' impressions of the industry. Creyer EH; Hrsistodoulakis I Mark Health Serv; 1998; 18(2):34-8. PubMed ID: 10180333 [TBL] [Abstract][Full Text] [Related]
15. Medicine goes Madison Avenue: an evaluation of the effect of direct-to-consumer pharmaceutical advertising on the learned intermediary doctrine. Allen MC Spec Law Dig Health Care Law; 1998 Dec; (236):9-29. PubMed ID: 10187553 [No Abstract] [Full Text] [Related]
16. AAFP supports improvement, not ban, on direct-to-consumer prescription drug ads. Kellerman R; Ann Fam Med; 2007; 5(2):180-1. PubMed ID: 17389544 [No Abstract] [Full Text] [Related]
17. The effects and role of direct-to-physician marketing in the pharmaceutical industry: an integrative review. Manchanda P; Honka E Yale J Health Policy Law Ethics; 2005; 5(2):785-822. PubMed ID: 16052900 [No Abstract] [Full Text] [Related]
18. Pharmaceutical advertising in the Journal. Glass AR N Engl J Med; 1992 Dec; 327(23):1688; author reply 1689. PubMed ID: 1435911 [No Abstract] [Full Text] [Related]
19. Pharmaceutical advertising in the Journal. Pierach CA N Engl J Med; 1992 Dec; 327(23):1688-9. PubMed ID: 1435912 [No Abstract] [Full Text] [Related]
20. New "law" attempts to explain strategies drug marketers use to sway prescribing. Mitka M JAMA; 2011 Mar; 305(11):1083-4. PubMed ID: 21406641 [No Abstract] [Full Text] [Related] [Next] [New Search]